Navigation Links
Cure For Persistent Oral Fungal Problem May Be Possible

Buffalo University dental researchers have identified some proteins that have anti-fungal properties and have the //potential to replace current drugs that are used to treat fungal infections of the mouth.

These peptides have strong anti-fungal properties, even against fungal infections that become resistant to medication. Also the properties of these peptides can be increased if they can be protected from the enzymes that may destroy them.

This may be achieved by synthesizing a protease inhibitor cocktail that may inhibit the enzymes that kill the peptides. This cocktail thus may be able to increase the ability of the peptides to treat potential oral infections up to double their original power.

One peptide called MUC7 12-mer, which occurs naturally in the human salivary mucin molecule is quite effective for treating oral fungal infections. Even active in very low concentrations, when used with inhibitors, the peptide killed the fungal agents that cause very common infections like candidiasis and cryptococcosis. These can be an especially effective treatment for patients having immunity suppressing drugs, like those suffering from HIV-AIDS, Organ transplant patients and chemotherapy patients.

http://www.buffalo.edu/news/fast-execute.cgi/article-
page.html?article=66080009
'"/>




Page: 1

Related medicine news :

1. Persistent Childhood Wheeze Probably Inherited
2. Persistent Fatigue Could Be An Early Indicator Of Postpartum Depression
3. Women More Persistent with Monthly Osteoporosis Treatment
4. Insurance Data Show High Costs of Persistent Asthma
5. Fungal Infections Effectively Controlled By Light Therapy
6. Fungal spores in the pillows can trigger an asthma attack
7. Immunosuppressive Action Of Fungal Metabolite - Gliotoxin
8. Fungal toxins infected corn the reason for congenital defects
9. Contact Lenses Implicated in Fungal Infections
10. Spread Of Fungal Infections At Gym Could Be Avoided By Using Towel
11. Lens Wearers Alerted Over Dangerous Fungal Infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... The Justin Veatch Fund ... (NCADD) is recommending the film Whispering Spirits and its discussion guide for ... as an education tool in the war against teen drug abuse. NCADD is ...
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the ... advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, ... Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up with ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... 10.2 version gives development continuity to its innovative Unified Instance Manager architecture, ... capacity. In addition, this new version optimizes the unattended auto-dialing system without ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: